BCRX

BioCryst制药

• TipRanks·12h ago

  Bank of America Securities Keeps Their Buy Rating on BioCryst (BCRX)

• TipRanks·20h ago

  RBC Capital Sticks to Its Hold Rating for BioCryst (BCRX)

• Simply Wall St·1d ago

  BioCryst Pharmaceuticals (BCRX) Names Scientific Advisory Board, Is The Discount Too Wide?

• Simply Wall St·4d ago

  Did New Science Board Just Shift BioCryst's (BCRX) Investment Narrative?

• Dow Jones·09/30 18:04

  BioCryst Pharmaceuticals Is Maintained at Neutral by JP Morgan

• Dow Jones·09/30 18:04

  BioCryst Pharmaceuticals Price Target Raised to $13.00/Share From $12.00 by JP Morgan

• Benzinga·09/30 17:55

  JP Morgan Maintains Neutral on BioCryst Pharma, Raises Price Target to $13

• TipRanks·09/30 11:30

  BioCryst price target raised to $13 from $12 at JPMorgan

• Seeking Alpha·09/24 13:39

  Novo Nordisk: Capital Markets Day Reveals Its Next Growth Engine

• Simply Wall St·09/24 05:27

  Will Japan Pediatric Approval Change BioCryst Pharmaceuticals (BCRX) Narrative

• Seeking Alpha·09/23 15:26

  BofA identifies Russell 2000 stocks positioned for Fed hiking cycles

• Simply Wall St·09/20 10:17

  BioCryst Pharmaceuticals (BCRX) Puts Orladeyo Growth And Valuation Back In Focus

• NASDAQ·09/19 02:01

  BioCryst Eyes $1B Rare-Disease Future Through External Innovation

• Seeking Alpha·09/15 17:15

  Undervalued healthcare stocks with attractive valuation grades

• TipRanks·09/15 15:36

  3 Best Stocks With 140%+ Upside to Buy This Week, According to Analysts